NCT03683251

Extension Study for the Port Delivery System With Ranibizumab (Portal)

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2018-09-20Est. Completion: 2029-12-31

Enrollment target: 1,000 participants

Locations

Retinal Research Institute, LLC, Phoenix, Arizona, United States
Arizona Retina and Vitreous Consultants, Phoenix, Arizona, United States
Barnet Dulaney Perkins Eye Center, Phoenix, Arizona, United States
Associated Retina Consultants, Phoenix, Arizona, United States
Retinal Consultants of Arizona, Phoenix, Arizona, United States
California Retina Consultants, Bakersfield, California, United States
Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States
The Retina Partners, Encino, California, United States
Jacobs Retina center at the Shiley eye Institute UCSD, La Jolla, California, United States
Jules Stein Eye Institute/ UCLA, Los Angeles, California, United States
N CA Retina Vitreous Assoc, Mountain View, California, United States
Retina Consultants, San Diego, Poway, California, United States
Retinal Consultants Med Group, Sacramento, California, United States
West Coast Retina Medical Group, San Francisco, California, United States
UCSF, San Francisco, California, United States

Neovascular Age-related Macular Degeneration (nAMD)

This study is a Phase IIIb/IV, multicenter, randomized, two-arm, open-label 100-week study to investigate the efficacy, …

Santa Ana, United StatesEst. completion Oct 16, 2026

Macular DegenerationWet Macular DegenerationRetinal DegenerationRetinal DiseasesEye Diseases

The purpose of the current study is to evaluate the ability of Eylea to induce a regression of PED height on patients pr…

Bordeaux, France

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.